Literature DB >> 32296833

Quantitative mapping of binding specificity landscapes for homologous targets by using a high-throughput method.

Lidan Aharon1, Shay-Lee Aharoni1, Evette S Radisky2, Niv Papo1.   

Abstract

To facilitate investigations of protein-protein interactions (PPIs), we developed a novel platform for quantitative mapping of protein binding specificity landscapes, which combines the multi-target screening of a mutagenesis library into high- and low-affinity populations with sophisticated next-generation sequencing analysis. Importantly, this method generates accurate models to predict affinity and specificity values for any mutation within a protein complex, and requires only a few experimental binding affinity measurements using purified proteins for calibration. We demonstrated the utility of the approach by mapping quantitative landscapes for interactions between the N-terminal domain of the tissue inhibitor of metalloproteinase 2 (N-TIMP2) and three matrix metalloproteinases (MMPs) having homologous structures but different affinities (MMP-1, MMP-3, and MMP-14). The binding landscapes for N-TIMP2/MMP-1 and N-TIMP2/MMP-3 showed the PPIs to be almost fully optimized, with most single mutations giving a loss of affinity. In contrast, the non-optimized PPI for N-TIMP2/MMP-14 was reflected in a wide range of binding affinities, where single mutations exhibited a far more attenuated effect on the PPI. Our new platform reliably and comprehensively identified not only hot- and cold-spot residues, but also specificity-switch mutations that shape target affinity and specificity. Thus, our approach provides a methodology giving an unprecedentedly rich quantitative analysis of the binding specificity landscape, which will broaden the understanding of the mechanisms and evolutionary origins of specific PPIs and facilitate the rational design of specific inhibitors for structurally similar target proteins.
© 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  metalloproteases; next-generation sequencing; protease inhibitor; protein engineering; protein–protein interactions

Mesh:

Substances:

Year:  2020        PMID: 32296833      PMCID: PMC7376575          DOI: 10.1042/BCJ20200188

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  66 in total

Review 1.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

Review 2.  Matrix metalloproteinases and epidermal wound repair.

Authors:  Vera L Martins; Matthew Caley; Edel A O'Toole
Journal:  Cell Tissue Res       Date:  2012-04-18       Impact factor: 5.249

3.  Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.

Authors:  Valeria Arkadash; Gal Yosef; Jason Shirian; Itay Cohen; Yuval Horev; Moran Grossman; Irit Sagi; Evette S Radisky; Julia M Shifman; Niv Papo
Journal:  J Biol Chem       Date:  2017-01-13       Impact factor: 5.157

4.  Structural basis of affinity maturation and intramolecular cooperativity in a protein-protein interaction.

Authors:  Sangwoo Cho; Chittoor P Swaminathan; Jianying Yang; Melissa C Kerzic; Rongjin Guan; Michele C Kieke; David M Kranz; Roy A Mariuzza; Eric J Sundberg
Journal:  Structure       Date:  2005-12       Impact factor: 5.006

Review 5.  Laboratory evolution of protein conformational dynamics.

Authors:  Eleanor C Campbell; Galen J Correy; Peter D Mabbitt; Ashley M Buckle; Nobuhiko Tokuriki; Colin J Jackson
Journal:  Curr Opin Struct Biol       Date:  2017-11-08       Impact factor: 6.809

6.  Phage display of tissue inhibitor of metalloproteinases-2 (TIMP-2): identification of selective inhibitors of collagenase-1 (metalloproteinase 1 (MMP-1)).

Authors:  Harinath Bahudhanapati; Yingnan Zhang; Sachdev S Sidhu; Keith Brew
Journal:  J Biol Chem       Date:  2011-06-29       Impact factor: 5.157

7.  Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.

Authors:  C Fernandez-Catalan; W Bode; R Huber; D Turk; J J Calvete; A Lichte; H Tschesche; K Maskos
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

8.  Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.

Authors:  Jyotica Batra; Alexei S Soares; Christine Mehner; Evette S Radisky
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

9.  Neutral genetic drift can alter promiscuous protein functions, potentially aiding functional evolution.

Authors:  Jesse D Bloom; Philip A Romero; Zhongyi Lu; Frances H Arnold
Journal:  Biol Direct       Date:  2007-06-28       Impact factor: 4.540

10.  MT1-MMP is not a good prognosticator of cancer survival: evidence from 11 studies.

Authors:  Kun-Peng Wu; Qiang Li; Fu-Xiang Lin; Jun Li; Lu-Min Wu; Wei Li; Qiao-Zhu Yang
Journal:  Tumour Biol       Date:  2014-09-07
View more
  1 in total

1.  RNase H-dependent PCR enables highly specific amplification of antibody variable domains from single B-cells.

Authors:  John Crissman; Yuhao Lin; Kevin Separa; Madeleine Duquette; Michael Cohen; Candyd Velasquez; Thomas Cujec
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.